Clifford Allbutt Lecture Theatre, Clifford Allbutt Building (former LMB building)


2014-07-09 13:00: Dnmt3a in Normal and Malignant Hematopoiesis (Prof Margaret Goodell, Stem Cells and Regenerative Medicine Center, Baylor College of Medicine)

2014-09-08 16:30: Imaging experience dependent structural plasticity (Heidi Johansen-Berg   University of Oxford)

2014-09-08 18:00: Myelin, movement and motor skills (Professor William Richardson)

2014-09-25 17:00: Myelin Disposal (Hartmut B. Frederik Pohl - IDIBELL Institute Barcelona and Dept. of Clinical Neuroscience, University of Cambridge)

2014-10-06 17:00: Myelin Disposal (Dr. Hartmut B. Frederik Pohl - IDIBELL Institute Barcelona and University of Cambridge)

2014-11-03 17:00: Are oligodendrocyte progenitors in the adult brain generating oligodendrocytes? In vivo approaches to understand precursor cells outside the neurogenic niches (Dr. Leda Dimou-Rörentrop Physiological Genomics LMU Munich)

2015-01-29 16:00: Opening up the stem cell niche for human and mouse hematopoietic stem cells (Prof. Claudia Waskow, Center for Regenerative Therapies TU Dresden)

2015-06-01 17:00: Glutathione-dependent blood flow regulation by astrocytes (Dr Clare Howarth,  University of Sheffield)

2015-07-06 17:00: Multiple sclerosis viewed from a tissue energy perspective (Prof. Kenneth J. Smith)

2016-03-10 17:00: Cambridge Haematopoiesis Seminars: Timm Schroeder & Ellen Rothenberg  (Timm Schroeder - ETH Zurich & Ellen Rothenburg - Caltech)

2016-10-14 12:00: Marginal zone lymphoma:  a paradigm of oncogenic cooperation between genetic changes and antigenic drive (Ming-Qing Du)

2016-12-08 16:30: Toward Eliminating Patient Harm  (Peter Pronovost, M.D., Ph.D., FCCM, director of the Armstrong Institute for Patient Safety and Quality at Johns Hopkins, Johns Hopkins Medicine’s senior vice president for patient safety and quality)

2016-12-08 16:30: Toward Eliminating Patient Harm  (Peter Pronovost, M.D., Ph.D., FCCM, director of the Armstrong Institute for Patient Safety and Quality at Johns Hopkins, Johns Hopkins Medicine’s senior vice president for patient safety and quality)

2017-02-16 10:00: Lineage-specific genes are prominent DNA damage hotspots during leukemic transformation of B-cell precursors (Niklas Feldhahn; Imperial College London)

2017-02-28 17:00: Managing demand and maintaining quality in emergency medicine: a view from the US on clinically efficacious flow (Dr Carol Barsky M.D., M.B.A Vice President and Chief Quality and Patient Safety Officer of Hackensack University Health Network, New Jersey)

2017-03-15 10:00: Aberrant Ubiquitin Networks in B cell malignancies (Florian Bassermann; Technische Universitat Munchen)

2017-06-07 11:00: CRISPR-Cas9 genetic screens uncover B cell receptor-MYD88 superpathwayin Diffuse Large B Cell Lymphoma (Ryan Young; NIH National Cancer Institute, Bethesda, USA)

2017-09-29 11:00: “BCL6, MYC and the Germinal Centre Reaction: What are we ‘MIZ’-sing?”	 (Dinis Calado)

2017-10-27 12:00: “Imaging the immune system” (Pavel Tolar)